Abstract
Terpenoid compounds of natural origin with antiviral activities, namely triterpenes and steroids, include compounds with potential future medical use as well as substances in different stages of clinical research and testing. These natural compounds have often been synthetically modified, the modification including both changes in the basic structure or mere substituent modifications.
Keywords: Sterols, Triterpenoids, Antiviral Activity, natural compounds
Anti-Infective Agents in Medicinal Chemistry
Title: Sterols and Triterpenoids with Antiviral Activity
Volume: 8 Issue: 3
Author(s): T. Rezanka, L. Siristova and K. Sigler
Affiliation:
Keywords: Sterols, Triterpenoids, Antiviral Activity, natural compounds
Abstract: Terpenoid compounds of natural origin with antiviral activities, namely triterpenes and steroids, include compounds with potential future medical use as well as substances in different stages of clinical research and testing. These natural compounds have often been synthetically modified, the modification including both changes in the basic structure or mere substituent modifications.
Export Options
About this article
Cite this article as:
Rezanka T., Siristova L. and Sigler K., Sterols and Triterpenoids with Antiviral Activity, Anti-Infective Agents in Medicinal Chemistry 2009; 8 (3) . https://dx.doi.org/10.2174/187152109788680207
DOI https://dx.doi.org/10.2174/187152109788680207 |
Print ISSN 1871-5214 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6018 |
Related Articles
-
miR-126 as a Therapeutic Agent for Diabetes Mellitus
Current Pharmaceutical Design Effects of Anticancer Drugs in Reproductive Parameters of Juvenile Male Animals and Role of Protective Agents
Anti-Cancer Agents in Medicinal Chemistry 3,4,5-Trisubstituted-1,2,4-triazole Derivatives as Antiproliferative Agents: Synthesis, In vitro Evaluation and Molecular Modelling
Letters in Drug Design & Discovery Targets for Anti-metastatic Drug Development
Current Pharmaceutical Design Aflibercept (VEGF-TRAP): The Next Anti-VEGF Drug
Inflammation & Allergy - Drug Targets (Discontinued) Radiolabelled Probes Targeting Tumor Hypoxia for Personalized Medicine
Current Pharmaceutical Design Recent Advances in Synthesis and Identification of Cyclic Peptides for Bioapplications
Current Topics in Medicinal Chemistry New Targets for the Modulation of Radiation Response - Selective Inhibition of the Enzyme Cyclooxygenase 2
Current Medicinal Chemistry - Anti-Cancer Agents Induced Stem Cells as a Novel Multiple Sclerosis Therapy
Current Stem Cell Research & Therapy p53 Activation by Blocking Snail : A Novel Pharmacological Strategy for Cancer
Current Pharmaceutical Design The Emerging Roles of the HERC Ubiquitin Ligases in Cancer
Current Pharmaceutical Design Eriocalyxin B-Induced Apoptosis in Pancreatic Adenocarcinoma Cells Through Thiol-Containing Antioxidant Systems and Downstream Signalling Pathways
Current Molecular Medicine Evaluation of Anticancer, Antibacterial and Antioxidant Properties of a Medicinally Treasured Fern Tectaria coadunata with its Phytoconstituents Analysis by HR-LCMS
Anti-Cancer Agents in Medicinal Chemistry Preface
Current Protein & Peptide Science Involvement of Membrane Channels in Autoimmune Disorders
Current Pharmaceutical Design Protein Microarrays: Technological Aspects, Applications and Intellectual Property
Recent Patents on Biotechnology Pharmacogenetics of Colon Cancer and Potential Implications for 5- Fluorouracil-Based Chemotherapy
Current Pharmacogenomics Deciphering the Systems Biology of mTOR Inhibition by Integrative Transcriptome Analysis
Current Pharmaceutical Design Use of Cell Lines in the Investigation of Pharmacogenetic Loci
Current Pharmaceutical Design Integrins in Drug Targeting-RGD Templates in Toxins
Current Pharmaceutical Design